A Phase 2, Multicenter, Randomized, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) ClinicalTrials.gov, 8 Oct 2013 Accessed on 25 Jun 2014 from http://clinicaltrials.gov/ct2/show/NCT01453205. CommentRecommendBookmarkWatch